Diabetic nephropathy (DN) is a serious complication of diabetes associated with increased
risk of mortality, and cardiovascular and renal outcomes. Diagnostic markers to detect DN at …

Diabetic nephropathy (DN) is a well-described complication of diabetes mellitus and the
leading cause of end stage renal disease (ESRD). Although increased albuminuria has …

Introduction Renal tubulo-interstitial damage has an important role in the pathogenesis of
early diabetic nephropathy. Urinary biomarkers can help in the detection of early …

Materials and Methods: This cross-sectional hospital-based study included 180 patients with
type 2 DM according to the American Diabetes Association criteria. Serum NGAL (S. NGAL) …

Background Diabetes mellitus is the leading cause of end stage renal disease worldwide.
Early identification of diabetic nephropathy even before appearance of microalbuminuria is …

Background: Diabetic nephropathy (DN) occurs in 20%–40% of patients with diabetes, and it
is characterized by proteinuria and progressive loss of renal functions ultimately leading to …

The current study the effect of urine and serum cystatin in diabetic nephropathy patients in
Najaf. This investigation was carried out at the Al-Sadr Teaching Hospital in Najaf's Diabetes …

Cystatin C - A Biomarker for Early Nephropathy in Type 2 Diabetic Patients Page 1 Review
Article Open Access Molecular Biomarkers & Diagnosis Jo urn al o f M olecular Biomarkers …

Context Diabetic nephropathy in type 2 diabetes mellitus is one of the most serious
microvascular complications. Immunoglobulin G (IgG), with molecular weight of 150 kDa, is …

Background: Diabetes mellitus is a group of metabolic diseases characterized by
hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Diagnostic …